SEC Form 4 · accession 0001209191-15-077469

ZEVRA THERAPEUTICS, INC. · ZVRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President & CEO · Director · 10% Owner

Period of report

Oct 28, 2015

Accepted (ET)

Oct 30, 2015 · 4:41 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001434647

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Oct 2, 2015	G	157,197	$0.00	D	1,381,176	D
Common Stock	Oct 2, 2015	G	157,197	$0.00	A	157,197	I	By Travis C. Mickle 2015 Dynasty Trust dtd 7/21/15, by spouse as trustee
Common Stock	Oct 2, 2015	G	243,880	$0.00	D	33,214	I	By Spouse
Common Stock	Oct 2, 2015	G	243,880	$0.00	A	243,880	I	By Christal M.M. Mickle 2015 Gift Trust, as trustee
Common Stock^F1	Oct 28, 2015	X	4,316	$5.85	A	100,604	D
Common Stock	holding	—	—		—	230,812	I	By Travis C Mickle & Christal M.M. Mickle TRS UA 4-30-09 Mickle Family Trust, co-trustee with spouse
Common Stock	holding	—	—		—	230,812	I	By Travis C Mickle & Christal M.M. Mickle TRS UA 4-30-09 TCM Family Trust, co-trustee with spouse

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrant to Purchase Common Stock (right to buy)^F1,F2,F3	$5.85	Oct 28, 2015	X	4,316	D	—	—	Common Stock	4,316	0	D

F1Held jointly with spouse.
F2The warrant is immediately exercisable at any time at the option of the holder.
F3The warrant expires as of 5:00 p.m. C.S.T. on the earliest of (i) June 2, 2019 and (ii) the effective date of the closing of a Company Sale Transaction (as such term is defined in the warrant).